An IPA interaction network analysis revealed the genes CCND1, CDK1A, CDK1B, Cyclin E (also known as CCNE1), and EGFR at the interface between the gemcitabine pathway and the pancreatic cancer signaling (Figure 8). This evidence concerns the gene EGFR and pancreatic neoplasm.